Streetbeat News

Analyst Ratings

PCRX

Jefferies analyst Glen Santangelo maintains a Buy rating on Pacira BioSciences and raises the price target from $15 to $18.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:43 pm

CYBR

Jefferies analyst Joseph Gallo maintains a Buy rating on CyberArk Software and raises the price target from $315 to $330.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:40 pm

CRWD

Jefferies analyst Joseph Gallo maintains a Buy rating on CrowdStrike Holdings and raises the price target from $315 to $345.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:37 pm

CHKP

Jefferies analyst Joseph Gallo maintains a Buy rating on Check Point Software and raises the price target from $210 to $225.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:34 pm

NVO

Novo Nordisk has seen significant options activity, with a bullish sentiment from big investors. The stock is currently trading at $125.52, with a price target of $160 set by analysts. The options market indicates a price range of $90 to $150.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 3:30 pm

EL

DA Davidson analyst Linda Bolton Weiser maintains a Buy rating on Estee Lauder Cos (NYSE:EL) with a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:26 pm

AMZN

GOOG

META

PINS

Pinterest's stock rose after Ark Invest's purchase, with Oppenheimer's analyst giving it an Outperform rating and a $45 price target. The company shows potential for increased monetization through ad improvements and third-party integrations with Amazon and Alphabet.

Portfolio Pulse from Priya Nigam

September 24, 2024 | 3:25 pm

NHI

B of A Securities has initiated coverage on National Health Investors (NYSE:NHI) with a Buy rating and set a price target of $92.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:22 pm

INVH

B of A Securities has downgraded Invitation Homes from Buy to Neutral and lowered its price target from $39 to $37.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:21 pm

DRS

B of A Securities has downgraded Leonardo DRS from Buy to Neutral, while raising its price target from $26 to $30.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:19 pm